MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TSAI, B. S.
Right arrow Articles by LEFKOWITZ, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TSAI, B. S.
Right arrow Articles by LEFKOWITZ, R. J.

Molecular Pharmacology, Vol 14, 540-548, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

Agonist-Specific Effects of Monovalent and Divalent Cations on Adenylate Cyclase-Coupled Alpha Adrenergic Receptors in Rabbit Platelets

BIE SHUNG TSAI 1 and ROBERT J. LEFKOWITZ 1

1 Department of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

The alpha adrenergic receptors of rabbit platelets can be identified by using [3H]-dihydroergocryptine. The binding of [3H]dihydroergocryptine to platelet lysates reaches equilibrium in 30 min and is slowly reversible. The maximal number of binding sites is 280 ± 25 fmoles/mg, and the dissociation constant was determined to be 2.26 ± 0.48 nM. The specificity of the binding sites for receptor agonists and antagonists is consistent with that of an alpha adrenergic response in inhibiting prostaglandin E1-stimulated adenylate cyclase in the same lysate preparation and is thus in agreement with the classical definition of alpha adrenergic receptors in mediating physiological responses. Divalent cations such as magnesium and manganese and monovalent cations such as sodium markedly influence the binding affinity of agonists but have little or no effect on the binding of antagonists. Calcium produces no change in binding. Neither magnesium nor sodium alters the number of receptor sites. Magnesium (1.25 mM) increases the binding affinity of (-)-epinephrine by a factor of 4. In contrast, sodium chloride (100 mM) strikingly decreases the binding affinity of agonists (more than 10-fold). The effect of sodium chloride on agonists is apparent with concentrations as low as 10 mM, and shows a dose-dependent response. LiCl and KCl are only 44% and 19% as effective, respectively, as sodium chloride. The magnitude of the shift in binding affinity of alpha adrenergic agents produced by sodium chloride is directly related to the intrinsic activity of those agents for inhibition of prostaglandin E1-stimulated adenylate cyclase. The results suggest that physiological concentrations of magnesium chloride and sodium chloride may selectively regulate the binding affinity of agonists.

Submitted on January 20, 1978
Accepted on March 9, 1978




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y.-H. Feng, L. Zhou, R. Qiu, and R. Zeng
Single Mutations at Asn295 and Leu305 in the Cytoplasmic Half of Transmembrane {alpha}-Helix Domain 7 of the AT1 Receptor Induce Promiscuous Agonist Specificity for Angiotensin II Fragments: A Pseudo-Constitutive Activity
Mol. Pharmacol., August 1, 2005; 68(2): 347 - 355.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. H. Wilson, H. A. Highfield, and L. E. Limbird
The Role of a Conserved Inter-Transmembrane Domain Interface in Regulating {alpha}2a-Adrenergic Receptor Conformational Stability and Cell-Surface Turnover
Mol. Pharmacol., April 1, 2001; 59(4): 929 - 938.
[Abstract] [Full Text]


Home page
HypertensionHome page
K. P. Makaritsis, C. Johns, I. Gavras, and H. Gavras
Role of {alpha}2-Adrenergic Receptor Subtypes in the Acute Hypertensive Response to Hypertonic Saline Infusion in Anephric Mice
Hypertension, February 1, 2000; 35(2): 609 - 613.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. P. Makaritsis, C. Johns, I. Gavras, J. D. Altman, D. E. Handy, M. R. Bresnahan, and H. Gavras
Sympathoinhibitory Function of the {alpha}2A-Adrenergic Receptor Subtype
Hypertension, September 1, 1999; 34(3): 403 - 407.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. P. Makaritsis, D. E. Handy, C. Johns, B. Kobilka, I. Gavras, and H. Gavras
Role of the {alpha}2B-Adrenergic Receptor in the Development of Salt-Induced Hypertension
Hypertension, January 1, 1999; 33(1): 14 - 17.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics